|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.9466 USD | -7.20% |
|
-10.70% | -3.31% |
Company Valuation: Cocrystal Pharma, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 63.35 | 15.88 | 17.52 | 20.55 | 13.49 | 18.23 | - | - |
| Change | - | -74.94% | 10.34% | 17.29% | -34.34% | 35.12% | - | - |
| Enterprise Value (EV) | 63.35 | 15.88 | 17.52 | 20.55 | 13.49 | 18.23 | 18.23 | 18.23 |
| Change | - | -74.94% | 10.34% | 17.29% | -34.34% | 35.12% | 0% | 0% |
| P/E | -4.06x | -0.41x | -0.92x | -1.17x | -1.26x | -1.31x | -1.99x | -1.5x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | 0x | 0.15x | 0x | 0.19x | 0.1x | -0x |
| Capitalization / Revenue | - | - | - | - | - | 0.17x | - | - |
| EV / Revenue | - | - | - | - | - | 0.17x | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -1.55x | -1.67x | -1.28x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.92 | -4.77 | -1.87 | -1.72 | -0.78 | -0.725 | -0.475 | -0.63 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 110 | - | - |
| EBITDA | - | - | -18.37 | - | - | - | - | - |
| EBIT 1 | -14.22 | -38.83 | -18.56 | -17.88 | -9.019 | -11.8 | -10.9 | -14.2 |
| Net income 1 | -14.18 | -38.84 | -17.98 | -17.5 | -8.831 | -11.66 | -10.75 | -13.9 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 7.8000 | 1.9500 | 1.7222 | 2.0200 | 0.9790 | 0.9466 | 0.9466 | 0.9466 |
| Nbr of stocks (in thousands) | 8,122 | 8,143 | 10,174 | 10,174 | 13,784 | 19,263 | - | - |
| Announcement Date | 3/23/22 | 3/29/23 | 3/28/24 | 3/31/25 | 3/31/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.31x | - | - | - | 18.23M | |
| 19.06x | 6.78x | 13.59x | 1.56% | 65.83B | |
| 35.71x | 6.35x | 18.96x | 0.91% | 51.87B | |
| 27.56x | 7.53x | 23.84x | 0.05% | 51.2B | |
| 33.88x | 3.31x | 14.28x | -.--% | 43.76B | |
| 48.73x | 5.61x | 30.83x | -.--% | 42.09B | |
| -18.92x | 193.08x | -20x | -.--% | 39.04B | |
| 29.6x | 8.38x | 21.69x | 0.36% | 34B | |
| 29.17x | 6.17x | 16.01x | -.--% | 25.2B | |
| 31.2x | 5.77x | 19.4x | -.--% | 22.8B | |
| Average | 23.47x | 27.00x | 15.40x | 0.32% | 37.58B | |
| Weighted average by Cap. | 25.99x | 25.69x | 15.50x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- COCP Stock
- Valuation Cocrystal Pharma, Inc.
Select your edition
All financial news and data tailored to specific country editions
